“A double-blind, placebo-controlled, randomized phase III trial of gemcitabine (G) plus bevacizumab (B) versus gemcitabine plus placebo (P) in patients (pts) with advanced pancreatic cancer (PC): A preliminary analysis of Cancer and Leukemia Group B (CALGB)”. - Kindler,H.; Niedzwiecki,D. (J Clin Oncol ASCO Annual Meeting Proceedings Part I, 2007)